We want patients to have a superior real-life experience

MC2 Therapeutics is a privately held pharmaceutical company committed to introduce a new standard of topical therapies for chronic inflammatory conditions designed for fast relief of symptoms and convenience in daily routines thereby responding to patients’ requests.

Our proprietary PAD™ Technology allows us to go beyond technical limitations of conventional aqueous formulations such as creams and lotions and develop a new standard of innovative PAD™ Creams and PAD™ Eye Drops that are truly designed to become life companions for people with chronic inflammatory skin or eye conditions. A new upgraded experience for patients and an improved benefit-to-value proposition for payers and physicians.

Studies show that many chronic diseases such as psoriasis, atopic dermatitis, dry eye and dry itchy skin that are visible on the patient negatively affects the self-esteem and quality of life of many patients. Patients may feel even further stigmatized if their therapy affects their appearance or stain clothes and bedding because it makes their skin greasy and/or shiny or if it is difficult and time consuming to apply and use.

Patients with chronic inflammatory conditions may as many other people have sensitive skin that requires special care with a variety of moisturizing creams designed for high tolerability and repair of the skin barrier. PAD™ Technology uniquely enables PAD™ Creams that are made with multi-fold less surfactant compared to conventional creams and lotions thereby enabling creams designed for high tolerability. In addition to our pipeline of PAD™ Cream based drugs we are launching a novel non-drug PAD™ Cream based skin care line BioMee™ designed specifically for dry and sensitive skin. If you are a physician and are interested in dispensing BioMee™ Creams please click here.

We are committed to introduce a paradigm shift in topicals by developing PAD™ based therapies that patients will want to use every day.

We are satisfied when patients using PAD™ based therapies feel free to engage with other people and be as active and social as they want during treatment – we aim to respond beyond expectations.


We are dedicated to developing new topical drugs and healthcare products that patients will want to use

Read all about our platform, pipeline and purpose in our corporate presentation.

© mc2 therapeutics 2020